{"transactions":[{"id":2655536,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-24T17:19:17.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":12659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 22, 2021 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":12659,"derivative":{"exercise_price":32.93,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":12659},"source":{"system":"sec-edgar","filing":"0001567619-21-012594","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761921012594/doc1.xml","form_type":"4"}},{"id":2655535,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T17:19:17.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":3617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,617 Restricted Stock Units."}],"balance_after":23750,"source":{"system":"sec-edgar","filing":"0001567619-21-012594","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761921012594/doc1.xml","form_type":"4"}},{"id":2772853,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-24T18:11:10.000Z","date":"2021-03-22","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is early exercisable. One twelfth (1/12th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 27, 2019 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":12785,"derivative":{"exercise_price":4.73,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001567619-21-006887","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761921006887/doc1.xml","form_type":"4"}},{"id":2772852,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-24T18:11:10.000Z","date":"2021-03-22","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is early exercisable. One twenty-fourth (1/24th) of the shares initially subject to the option will vest on each monthly anniversary measured from August 9, 2019 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the second anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":16397,"derivative":{"exercise_price":4.73,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001567619-21-006887","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761921006887/doc1.xml","form_type":"4"}},{"id":2772851,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-24T18:11:10.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":3200,"price":49,"value":156800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":20133,"source":{"system":"sec-edgar","filing":"0001567619-21-006887","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761921006887/doc1.xml","form_type":"4"}},{"id":2772850,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-24T18:11:10.000Z","date":"2021-03-22","kind":"exercise","acquired":true,"shares":3200,"price":4.73,"value":15136.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":23333,"source":{"system":"sec-edgar","filing":"0001567619-21-006887","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761921006887/doc1.xml","form_type":"4"}},{"id":3009829,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-08T17:07:42.000Z","date":"2020-10-06","kind":"sale","acquired":false,"shares":6250,"price":39,"value":243750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":20133,"source":{"system":"sec-edgar","filing":"0001567619-20-017694","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761920017694/doc1.xml","form_type":"4"}},{"id":3019638,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-30T20:33:01.000Z","date":"2020-09-29","kind":"sale","acquired":false,"shares":450,"price":34.0722,"value":15332.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $34.00 to $34.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":26383,"source":{"system":"sec-edgar","filing":"0001567619-20-017293","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761920017293/doc1.xml","form_type":"4"}},{"id":3019637,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-30T20:33:01.000Z","date":"2020-09-28","kind":"sale","acquired":false,"shares":5300,"price":34.108,"value":180772.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $34.00 to $34.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":26833,"source":{"system":"sec-edgar","filing":"0001567619-20-017293","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761920017293/doc1.xml","form_type":"4"}},{"id":3022251,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-25T16:29:46.000Z","date":"2020-09-23","kind":"sale","acquired":false,"shares":500,"price":34.02,"value":17010.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $34.00 to $34.0650, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":32133,"source":{"system":"sec-edgar","filing":"0001567619-20-017108","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761920017108/doc1.xml","form_type":"4"}},{"id":3103910,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T15:36:30.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":6329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 17, 2020 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":6329,"derivative":{"exercise_price":36.57,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":6329},"source":{"system":"sec-edgar","filing":"0001567619-20-012446","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761920012446/doc1.xml","form_type":"4"}},{"id":3103909,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T15:36:30.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":1808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":32633,"source":{"system":"sec-edgar","filing":"0001567619-20-012446","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584999/000156761920012446/doc1.xml","form_type":"4"}},{"id":3854991,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"stock option (right to buy)","published_at":"2018-08-02T16:07:53.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":14271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F4","text":"The amount reported represents the number of vested stock options cancelled in connection with the Tender Offer by Roche and converted into the right to receive an amount in cash equal to the product of (1) the offer price of $137 per share minus the per share exercise price of the vested stock options, multiplied by (2) the number of shares represented by such vested stock options, without interest and less any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents the non-qualified portion of a stock option granted on April 9, 2014 with vesting in equal quarterly installments beginning on June 30, 2014 until fully vested on March 31, 2018."}],"balance_after":0,"derivative":{"exercise_price":29.94,"expiration_date":"2024-04-09","underlying":"Common Stock","underlying_shares":14271},"source":{"system":"sec-edgar","filing":"0001209191-18-044931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044931/doc4.xml","form_type":"4"}},{"id":3854990,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-02T16:07:53.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":36186,"price":137,"value":4957482.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F3","text":"The amount reported represents the number of unvested restricted stock units cancelled in connection with the Tender Offer by Roche and converted into the right to receive an amount in cash equal to the product of (1) the offer price of $137 per share multiplied by (2) the number of shares represented by such unvested restricted stock units, without interest and less any required withholding taxes. Payments are subject to the original vesting schedule and vesting conditions applicable to the underlying unvested restricted stock units."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-044931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044931/doc4.xml","form_type":"4"}},{"id":3854989,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-02T16:07:53.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":30993,"price":137,"value":4246041.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount reported represents the number of shares sold by the reporting person in connection with the Tender Offer by Roche."}],"balance_after":36186,"source":{"system":"sec-edgar","filing":"0001209191-18-044931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044931/doc4.xml","form_type":"4"}},{"id":3872641,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-05T16:09:11.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":2909,"price":136.66,"value":397543.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported restricted stock units granted to the reporting person on (1) April 1, 2016 in Table I of the Form 4 filed on April 6, 2016, (2) May 1, 2017 in Table I of the Form 4 filed on May 3, 2017 and (3) April 1, 2018 in Table I of the Form 4 filed on April 3, 2018. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting events related to this securities sale."}],"balance_after":67179,"source":{"system":"sec-edgar","filing":"0001209191-18-041552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118041552/doc4.xml","form_type":"4"}},{"id":3920511,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-23T16:06:28.000Z","date":"2018-05-21","kind":"exercise","acquired":false,"shares":1570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was granted on April 9, 2014 and vested in equal quarterly installments beginning on June 30, 2014 until fully vested on March 31, 2018."}],"balance_after":0,"derivative":{"exercise_price":29.94,"expiration_date":"2024-04-09","underlying":"Common Stock","underlying_shares":1570},"source":{"system":"sec-edgar","filing":"0001209191-18-032563","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118032563/doc4.xml","form_type":"4"}},{"id":3920510,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-23T16:06:28.000Z","date":"2018-05-21","kind":"sale","acquired":false,"shares":1570,"price":85,"value":133450.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."}],"balance_after":70088,"source":{"system":"sec-edgar","filing":"0001209191-18-032563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118032563/doc4.xml","form_type":"4"}},{"id":3920509,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-23T16:06:28.000Z","date":"2018-05-21","kind":"exercise","acquired":true,"shares":1570,"price":29.94,"value":47005.8,"ownership":{"direct":true},"balance_after":71658,"source":{"system":"sec-edgar","filing":"0001209191-18-032563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118032563/doc4.xml","form_type":"4"}},{"id":3961039,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-18T16:07:38.000Z","date":"2018-04-16","kind":"sale","acquired":false,"shares":3283,"price":74.02,"value":243007.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.00 to $78.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":70088,"source":{"system":"sec-edgar","filing":"0001209191-18-025354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118025354/doc4.xml","form_type":"4"}},{"id":3973035,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-04-03T16:12:27.000Z","date":"2018-03-09","kind":"exercise","acquired":false,"shares":6811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on April 9, 2014 and vests in equal quarterly installments beginning on June 30, 2014 until fully vested on March 31, 2018."}],"balance_after":1570,"derivative":{"exercise_price":29.94,"expiration_date":"2024-04-09","underlying":"Common Stock","underlying_shares":6811},"source":{"system":"sec-edgar","filing":"0001209191-18-022893","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022893/doc4a.xml","form_type":"4/A","original_submission_date":"2018-03-13"}},{"id":3973034,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:12:27.000Z","date":"2018-03-09","kind":"sale","acquired":false,"shares":10000,"price":85,"value":850000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."}],"balance_after":63322,"source":{"system":"sec-edgar","filing":"0001209191-18-022893","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022893/doc4a.xml","form_type":"4/A","original_submission_date":"2018-03-13"}},{"id":3973033,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:12:27.000Z","date":"2018-03-09","kind":"sale","acquired":false,"shares":6811,"price":85,"value":578935.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."}],"balance_after":73322,"source":{"system":"sec-edgar","filing":"0001209191-18-022893","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022893/doc4a.xml","form_type":"4/A","original_submission_date":"2018-03-13"}},{"id":3973032,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:12:27.000Z","date":"2018-03-09","kind":"exercise","acquired":true,"shares":6811,"price":29.94,"value":203921.34,"ownership":{"direct":true},"balance_after":80133,"source":{"system":"sec-edgar","filing":"0001209191-18-022893","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022893/doc4a.xml","form_type":"4/A","original_submission_date":"2018-03-13"}},{"id":3973038,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:11:48.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":2529,"price":74.86,"value":189320.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on April 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.60 to $75.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":73371,"source":{"system":"sec-edgar","filing":"0001209191-18-022889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022889/doc4.xml","form_type":"4"}},{"id":3973037,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:11:48.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":354,"price":75,"value":26550.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on March 31, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported all restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect this vesting event."}],"balance_after":75900,"source":{"system":"sec-edgar","filing":"0001209191-18-022889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022889/doc4.xml","form_type":"4"}},{"id":3973036,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:11:48.000Z","date":"2018-04-01","kind":"grant","acquired":true,"shares":12932,"price":78.75,"value":1018395.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued pursuant to a Restricted Stock Unit Award Agreement and the Issuer's 2013 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in equal quarterly installments over a three-year period with the first installment vesting on July 1, 2018."}],"balance_after":76254,"source":{"system":"sec-edgar","filing":"0001209191-18-022889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022889/doc4.xml","form_type":"4"}},{"id":4001059,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-12T16:15:54.000Z","date":"2018-03-09","kind":"exercise","acquired":false,"shares":6811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on April 9, 2014 and vests in equal quarterly installments beginning on June 30, 2014 until fully vested on March 31, 2018."}],"balance_after":1570,"derivative":{"exercise_price":29.94,"expiration_date":"2024-04-09","underlying":"Common Stock","underlying_shares":6811},"source":{"system":"sec-edgar","filing":"0001209191-18-018862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118018862/doc4.xml","form_type":"4"}},{"id":4001058,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-12T16:15:54.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":10000,"price":85,"value":850000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."}],"balance_after":63322,"source":{"system":"sec-edgar","filing":"0001209191-18-018862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118018862/doc4.xml","form_type":"4"}},{"id":4001057,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-12T16:15:54.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":6811,"price":85,"value":578935.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."}],"balance_after":73322,"source":{"system":"sec-edgar","filing":"0001209191-18-018862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118018862/doc4.xml","form_type":"4"}},{"id":4001056,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-12T16:15:54.000Z","date":"2018-02-20","kind":"exercise","acquired":true,"shares":6811,"price":29.94,"value":203921.34,"ownership":{"direct":true},"balance_after":80133,"source":{"system":"sec-edgar","filing":"0001209191-18-018862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118018862/doc4.xml","form_type":"4"}},{"id":4040370,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to guy)","published_at":"2018-02-22T16:03:56.000Z","date":"2018-02-20","kind":"exercise","acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option was granted on May 21, 2013 and vested in equal quarterly installments beginning on April 1, 2014 until fully vested on January 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":7.12,"expiration_date":"2023-05-21","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001209191-18-012313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118012313/doc4.xml","form_type":"4"}},{"id":4040369,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-22T16:03:56.000Z","date":"2018-02-20","kind":"exercise","acquired":false,"shares":2633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on March 7, 2013 and vested in equal quarterly installments beginning on June 7, 2013 until fully vested on March 7, 2017."}],"balance_after":0,"derivative":{"exercise_price":4.16,"expiration_date":"2023-03-07","underlying":"Common Stock","underlying_shares":2633},"source":{"system":"sec-edgar","filing":"0001209191-18-012313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118012313/doc4.xml","form_type":"4"}},{"id":4040368,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-22T16:03:56.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":20000,"price":76.87,"value":1537400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.15 to $78.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":73322,"source":{"system":"sec-edgar","filing":"0001209191-18-012313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118012313/doc4.xml","form_type":"4"}},{"id":4040367,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-22T16:03:56.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":9375,"price":76.87,"value":720656.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.15 to $78.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":93322,"source":{"system":"sec-edgar","filing":"0001209191-18-012313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118012313/doc4.xml","form_type":"4"}},{"id":4040366,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-22T16:03:56.000Z","date":"2018-02-20","kind":"exercise","acquired":true,"shares":9375,"price":7.12,"value":66750.0,"ownership":{"direct":true},"balance_after":102697,"source":{"system":"sec-edgar","filing":"0001209191-18-012313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118012313/doc4.xml","form_type":"4"}},{"id":4040365,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-22T16:03:56.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":2633,"price":76.87,"value":202398.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.15 to $78.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":93322,"source":{"system":"sec-edgar","filing":"0001209191-18-012313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118012313/doc4.xml","form_type":"4"}},{"id":4040364,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-22T16:03:56.000Z","date":"2018-02-20","kind":"exercise","acquired":true,"shares":2633,"price":4.16,"value":10953.28,"ownership":{"direct":true},"balance_after":95955,"source":{"system":"sec-edgar","filing":"0001209191-18-012313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118012313/doc4.xml","form_type":"4"}},{"id":4083544,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-31T16:03:30.000Z","date":"2018-01-29","kind":"exercise","acquired":false,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on March 7, 2013 and vested in equal quarterly installments beginning on June 7, 2013 until fully vested on March 7, 2017."}],"balance_after":2633,"derivative":{"exercise_price":4.16,"expiration_date":"2023-03-07","underlying":"Common Stock","underlying_shares":4400},"source":{"system":"sec-edgar","filing":"0001209191-18-006186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118006186/doc4.xml","form_type":"4"}},{"id":4083543,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-31T16:03:30.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":4400,"price":75,"value":330000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."}],"balance_after":93322,"source":{"system":"sec-edgar","filing":"0001209191-18-006186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118006186/doc4.xml","form_type":"4"}},{"id":4083542,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-31T16:03:30.000Z","date":"2018-01-29","kind":"exercise","acquired":true,"shares":4400,"price":4.16,"value":18304.0,"ownership":{"direct":true},"balance_after":97722,"source":{"system":"sec-edgar","filing":"0001209191-18-006186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118006186/doc4.xml","form_type":"4"}},{"id":4091075,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-24T16:19:09.000Z","date":"2018-01-22","kind":"exercise","acquired":false,"shares":17187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 10, 2012 and vested in equal quarterly installments beginning on December 31, 2013 until fully vested on April 8, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.84,"expiration_date":"2022-01-10","underlying":"Common Stock","underlying_shares":17187},"source":{"system":"sec-edgar","filing":"0001209191-18-005100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118005100/doc4.xml","form_type":"4"}},{"id":4091074,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-24T16:19:09.000Z","date":"2018-01-22","kind":"sale","acquired":false,"shares":17187,"price":70.27,"value":1207730.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.00 to $71.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":93322,"source":{"system":"sec-edgar","filing":"0001209191-18-005100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118005100/doc4.xml","form_type":"4"}},{"id":4091073,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-24T16:19:09.000Z","date":"2018-01-22","kind":"exercise","acquired":true,"shares":17187,"price":0.84,"value":14437.08,"ownership":{"direct":true},"balance_after":110509,"source":{"system":"sec-edgar","filing":"0001209191-18-005100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118005100/doc4.xml","form_type":"4"}},{"id":4096167,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-18T16:04:26.000Z","date":"2018-01-17","kind":"exercise","acquired":false,"shares":5534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted on January 10, 2012 and vested in equal quarterly installments beginning on December 31, 2012 until fully vested on April 8, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.84,"expiration_date":"2022-01-10","underlying":"Common Stock","underlying_shares":5534},"source":{"system":"sec-edgar","filing":"0001209191-18-004229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004229/doc4.xml","form_type":"4"}},{"id":4096166,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-18T16:04:26.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":5408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted on January 10, 2012 and vested in equal quarterly installments beginning on December 31, 2012 until fully vested on April 8, 2016."}],"balance_after":5534,"derivative":{"exercise_price":0.84,"expiration_date":"2022-01-10","underlying":"Common Stock","underlying_shares":5408},"source":{"system":"sec-edgar","filing":"0001209191-18-004229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004229/doc4.xml","form_type":"4"}},{"id":4096165,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-18T16:04:26.000Z","date":"2018-01-17","kind":"sale","acquired":false,"shares":5534,"price":65.39,"value":361868.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.00 to $66.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":93322,"source":{"system":"sec-edgar","filing":"0001209191-18-004229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004229/doc4.xml","form_type":"4"}},{"id":4096164,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-18T16:04:26.000Z","date":"2018-01-17","kind":"exercise","acquired":true,"shares":5534,"price":0.84,"value":4648.56,"ownership":{"direct":true},"balance_after":98856,"source":{"system":"sec-edgar","filing":"0001209191-18-004229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004229/doc4.xml","form_type":"4"}},{"id":4096163,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-18T16:04:26.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":5408,"price":65.26,"value":352926.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.15 to $68.75, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":93322,"source":{"system":"sec-edgar","filing":"0001209191-18-004229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004229/doc4.xml","form_type":"4"}},{"id":4096162,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-18T16:04:26.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":5408,"price":0.84,"value":4542.72,"ownership":{"direct":true},"balance_after":98730,"source":{"system":"sec-edgar","filing":"0001209191-18-004229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004229/doc4.xml","form_type":"4"}},{"id":4096161,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-18T16:04:26.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":3813,"price":65.26,"value":248836.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.15 to $68.75, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":93322,"source":{"system":"sec-edgar","filing":"0001209191-18-004229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004229/doc4.xml","form_type":"4"}},{"id":4112030,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-03T17:18:56.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":709,"price":64,"value":45376.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on January 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.73 to $64.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The reporting person previously reported the restricted stock units granted to the reporting person on May 1, 2017 in Table I of the Form 4 filed on May 3, 2017.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":97135,"source":{"system":"sec-edgar","filing":"0001209191-18-001134","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118001134/doc4.xml","form_type":"4"}},{"id":4112029,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-03T17:18:56.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":1248,"price":64,"value":79872.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on January 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.73 to $64.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":97844,"source":{"system":"sec-edgar","filing":"0001209191-18-001134","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118001134/doc4.xml","form_type":"4"}},{"id":4112028,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-03T17:18:56.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":392,"price":64,"value":25088.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on December 31, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.73 to $64.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported all restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect this vesting event."}],"balance_after":99092,"source":{"system":"sec-edgar","filing":"0001209191-18-001134","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118001134/doc4.xml","form_type":"4"}},{"id":4112027,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-03T17:18:56.000Z","date":"2017-12-07","kind":"gift","acquired":false,"shares":500,"price":62.25,"value":31125.0,"ownership":{"direct":true},"balance_after":99484,"source":{"system":"sec-edgar","filing":"0001209191-18-001134","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118001134/doc4.xml","form_type":"4"}},{"id":4139212,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-07T16:04:18.000Z","date":"2017-12-05","kind":"sale","acquired":false,"shares":20000,"price":61.17,"value":1223400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.85 to $63.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":99984,"source":{"system":"sec-edgar","filing":"0001209191-17-064394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117064394/doc4.xml","form_type":"4"}},{"id":4192152,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-10-04T16:03:21.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":994,"price":38.8,"value":38567.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on October 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.48 to $38.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"The reporting person previously reported the restricted stock units granted to the reporting person on May 1, 2017 in Table I of the Form 4 filed on May 3, 2017.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":119984,"source":{"system":"sec-edgar","filing":"0001209191-17-055740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117055740/doc4.xml","form_type":"4"}},{"id":4192151,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-10-04T16:03:21.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":1625,"price":38.8,"value":63050.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on October 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.46 to $38.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":120978,"source":{"system":"sec-edgar","filing":"0001209191-17-055740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117055740/doc4.xml","form_type":"4"}},{"id":4192150,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-10-04T16:03:21.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":325,"price":38.8,"value":12610.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on September 30, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.48 to $38.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported all restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect this vesting event."}],"balance_after":122603,"source":{"system":"sec-edgar","filing":"0001209191-17-055740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117055740/doc4.xml","form_type":"4"}},{"id":4260874,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-07T16:03:24.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":677,"price":38.84,"value":26294.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"The reporting person previously reported the restricted stock units granted to the reporting person on May 1, 2017 in Table I of the Form 4 filed on May 3, 2017.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":122928,"source":{"system":"sec-edgar","filing":"0001209191-17-044358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044358/doc4.xml","form_type":"4"}},{"id":4260873,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-07T16:03:24.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":1108,"price":38.84,"value":43034.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":123605,"source":{"system":"sec-edgar","filing":"0001209191-17-044358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044358/doc4.xml","form_type":"4"}},{"id":4260872,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-07T16:03:24.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":3363,"price":38.84,"value":130618.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on June 30, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reporting person previously reported restricted stock units granted to the reporting person on July 15, 2015 in Table I of the Form 4 filed on July 17, 2015. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":124713,"source":{"system":"sec-edgar","filing":"0001209191-17-044358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044358/doc4.xml","form_type":"4"}},{"id":4260871,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-07T16:03:24.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":260,"price":38.84,"value":10098.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on June 30, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported all restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect this vesting event."}],"balance_after":128076,"source":{"system":"sec-edgar","filing":"0001209191-17-044358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044358/doc4.xml","form_type":"4"}},{"id":4335222,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-05-03T16:02:24.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":24550,"price":35.8,"value":878890.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued pursuant to a Restricted Stock Unit Award Agreement and the Issuer's 2013 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in equal quarterly installments over a three-year period with the first installment occurring on August 1, 2017."}],"balance_after":128336,"source":{"system":"sec-edgar","filing":"0001209191-17-029599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117029599/doc4.xml","form_type":"4"}},{"id":4358232,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-05T16:06:21.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":1096,"price":31.96,"value":35028.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on April 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event on April 1, 2017."}],"balance_after":103786,"source":{"system":"sec-edgar","filing":"0001209191-17-025577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117025577/doc4.xml","form_type":"4"}},{"id":4358231,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-05T16:06:21.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":257,"price":31.96,"value":8213.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on March 31, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014.  As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event on March 31, 2017."}],"balance_after":104882,"source":{"system":"sec-edgar","filing":"0001209191-17-025577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117025577/doc4.xml","form_type":"4"}},{"id":4358230,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-05T16:06:21.000Z","date":"2017-03-13","kind":"gift","acquired":false,"shares":1000,"price":32.7,"value":32700.0,"ownership":{"direct":true},"balance_after":105139,"source":{"system":"sec-edgar","filing":"0001209191-17-025577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117025577/doc4.xml","form_type":"4"}},{"id":4498511,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-01-05T16:08:42.000Z","date":"2017-01-04","kind":"sale","acquired":false,"shares":1267,"price":18.49,"value":23426.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on January 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":106139,"source":{"system":"sec-edgar","filing":"0001209191-17-001973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117001973/doc4.xml","form_type":"4"}},{"id":4498510,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-01-05T16:08:42.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":259,"price":17.41,"value":4509.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on December 31, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.41 to $17.56, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event on December 31, 2016."}],"balance_after":107406,"source":{"system":"sec-edgar","filing":"0001209191-17-001973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117001973/doc4.xml","form_type":"4"}},{"id":4498509,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-01-05T16:08:42.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":3247,"price":17.41,"value":56530.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on December 30, 2016.  This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer.  This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.41 to $17.56, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported restricted stock units granted to the reporting person on July 15, 2015 in Table I of the Form 4 filed on July 17, 2015. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":107665,"source":{"system":"sec-edgar","filing":"0001209191-17-001973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117001973/doc4.xml","form_type":"4"}},{"id":4584390,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-10-05T16:07:29.000Z","date":"2016-10-04","kind":"sale","acquired":false,"shares":1084,"price":23.65,"value":25636.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on October 1, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $23.31 to $23.72, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":110912,"source":{"system":"sec-edgar","filing":"0001209191-16-144876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919116144876/doc4.xml","form_type":"4"}},{"id":4584389,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-10-05T16:07:29.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":258,"price":23.04,"value":5944.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on September 30, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.04 to $23.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event on June 30, 2016."}],"balance_after":111996,"source":{"system":"sec-edgar","filing":"0001209191-16-144876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919116144876/doc4.xml","form_type":"4"}},{"id":4584388,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":137924,"kind":"person","name":"Miller Vincent A.","position":1,"cik":"0001584999","reported_name":"Miller Vincent A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-10-05T16:07:29.000Z","date":"2016-09-13","kind":"gift","acquired":false,"shares":1400,"price":21.74,"value":30436.0,"ownership":{"direct":true},"balance_after":112254,"source":{"system":"sec-edgar","filing":"0001209191-16-144876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919116144876/doc4.xml","form_type":"4"}}]}